India · Delayed Price · Currency is INR Anthem Biosciences Statistics
Total Valuation
NSE:ANTHEM has a market cap or net worth of INR 425.04 billion. The enterprise value is 416.20 billion.
| Market Cap | 425.04B |
| Enterprise Value | 416.20B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Jun 25, 2026 |
Share Statistics
NSE:ANTHEM has 563.20 million shares outstanding. The number of shares has increased by 1.03% in one year.
| Current Share Class | 563.20M |
| Shares Outstanding | 563.20M |
| Shares Change (YoY) | +1.03% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 78.66% |
| Owned by Institutions (%) | 11.02% |
| Float | 72.07M |
Valuation Ratios
The trailing PE ratio is 72.36 and the forward PE ratio is 58.38. NSE:ANTHEM's PEG ratio is 2.43.
| PE Ratio | 72.36 |
| Forward PE | 58.38 |
| PS Ratio | 19.96 |
| PB Ratio | 13.97 |
| P/TBV Ratio | 13.97 |
| P/FCF Ratio | 67.11 |
| P/OCF Ratio | 50.33 |
| PEG Ratio | 2.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 49.40, with an EV/FCF ratio of 65.72.
| EV / Earnings | 70.33 |
| EV / Sales | 19.55 |
| EV / EBITDA | 49.40 |
| EV / EBIT | 58.75 |
| EV / FCF | 65.72 |
Financial Position
The company has a current ratio of 5.54, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.54 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.09 |
| Interest Coverage | 108.31 |
Financial Efficiency
Return on equity (ROE) is 21.71% and return on invested capital (ROIC) is 25.50%.
| Return on Equity (ROE) | 21.71% |
| Return on Assets (ROA) | 14.20% |
| Return on Invested Capital (ROIC) | 25.50% |
| Return on Capital Employed (ROCE) | 22.83% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.33M |
| Profits Per Employee | 2.59M |
| Employee Count | 2,282 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.67 |
Taxes
In the past 12 months, NSE:ANTHEM has paid 2.32 billion in taxes.
| Income Tax | 2.32B |
| Effective Tax Rate | 28.20% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 772.44 |
| 200-Day Moving Average | 708.48 |
| Relative Strength Index (RSI) | 44.83 |
| Average Volume (20 Days) | 576,318 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ANTHEM had revenue of INR 21.29 billion and earned 5.92 billion in profits. Earnings per share was 10.43.
| Revenue | 21.29B |
| Gross Profit | 12.75B |
| Operating Income | 7.08B |
| Pretax Income | 8.24B |
| Net Income | 5.92B |
| EBITDA | 8.40B |
| EBIT | 7.08B |
| Earnings Per Share (EPS) | 10.43 |
Balance Sheet
The company has 9.38 billion in cash and 539.24 million in debt, with a net cash position of 8.85 billion or 15.71 per share.
| Cash & Cash Equivalents | 9.38B |
| Total Debt | 539.24M |
| Net Cash | 8.85B |
| Net Cash Per Share | 15.71 |
| Equity (Book Value) | 30.43B |
| Book Value Per Share | 54.16 |
| Working Capital | 14.77B |
Cash Flow
In the last 12 months, operating cash flow was 8.44 billion and capital expenditures -2.11 billion, giving a free cash flow of 6.33 billion.
| Operating Cash Flow | 8.44B |
| Capital Expenditures | -2.11B |
| Depreciation & Amortization | 1.32B |
| Net Borrowing | -593.93M |
| Free Cash Flow | 6.33B |
| FCF Per Share | 11.25 |
Margins
Gross margin is 59.88%, with operating and profit margins of 33.27% and 27.79%.
| Gross Margin | 59.88% |
| Operating Margin | 33.27% |
| Pretax Margin | 38.71% |
| Profit Margin | 27.79% |
| EBITDA Margin | 39.46% |
| EBIT Margin | 33.27% |
| FCF Margin | 29.74% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.03% |
| Shareholder Yield | -0.76% |
| Earnings Yield | 1.39% |
| FCF Yield | 1.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ANTHEM is 879.43, which is 17.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 879.43 |
| Price Target Difference | 17.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 19.26% |
| EPS Growth Forecast (3Y) | 22.95% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NSE:ANTHEM has an Altman Z-Score of 64.61 and a Piotroski F-Score of 7.
| Altman Z-Score | 64.61 |
| Piotroski F-Score | 7 |